MIRA Pharmaceuticals News

MIRA Pharmaceuticals Submits IND for Ketamir-2 to FDA, Marking a Significant Milestone in the Company's Pipeline Development

AccesswireDec 19 09:00 ET

Express News | Mira Pharmaceuticals Inc - Submits Ind Application to FDA for Ketamir-2

ReutersDec 19 08:34 ET

Express News | Mira Pharmaceuticals Inc: Submission of Investigational New Drug (Ind) Application by End of 2024

ReutersDec 10 08:47 ET

Express News | EXCLUSIVE: Mira Pharmaceuticals Tells Benzinga 'Advancing Ketamir-2 Into Clinical Trials as Quickly as Possible Reflects Our Strategic Focus on Generating Proof-of-concept Data That Positions MIRA for a Potential M&A Transaction or Strategic Partnership'

BenzingaDec 10 08:15 ET

EXCLUSIVE: MIRA Pharmaceuticals Validates Ketamir-2's Safety Profile, Paving Way For Human Trials In Neuropathic Pain

BenzingaDec 10 08:15 ET

Express News | EXCLUSIVE: Mira Pharmaceuticals Tells Benzinga 'Strong Safety Profile Validated Across Studies, Setting the Stage for Clinical Trials in Neuropathic Pain'

BenzingaDec 10 08:15 ET

Express News | EXCLUSIVE: Mira Pharmaceuticals Tells Benzinga Co. Validates Ketamir-2's Safety Profile With No Adverse Finding, Says Paving The Way For IND Submission By Year-End

BenzingaDec 10 08:15 ET

MIRA Pharmaceuticals Appoints New Board Member and Chairman

TipRanksNov 21 16:48 ET

Express News | Mira Pharmaceuticals Announced The Selection Of The Centre For Human Drug Research In Leiden, The Netherlands, As The Site For Its Phase I/IIa Clinical Trial Of Ketamir-2, A Novel Oral Ketamine Analog

BenzingaNov 20 07:46 ET

MIRA Reveals Innovative Phase I/IIa Protocol Design and Selection of Clinical Trial Site

AccesswireNov 20 07:44 ET

US Manufacturing Index Rises To 43, Highest Since 2020

Business TodayNov 16 02:13 ET

MIRA Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

SECNov 12 16:50 ET · Announcements

Trending Stocks Today | Pixie Dust Technologies Shoots up 186.56% Post-Market

Moomoo NewsOct 25 18:00 ET

12 Health Care Stocks Moving In Friday's After-Market Session

BenzingaOct 25 16:31 ET

Express News | Watching MIRA Pharmaceuticals; Zacks Small-Cap Research Gives Stock $17.75 Price Valuation, Says Co Is Creating A THC Analog That Has The Same Benefits As THC Without The Negative Side Effects

BenzingaOct 21 10:09 ET

MIRA Pharmaceuticals Announces Ketamir-2 Outperforms Current FDA-Approved Neuropathic Pain Treatments, Gabapentin and Pregabalin, in Preclinical Study

AccesswireOct 21 07:30 ET

Express News | Mira Pharmaceuticals - Remains on Track to Submit Ind Application by End of 2024, With Phase I Clinical Trials Expected to Begin in Q1 2025

ReutersOct 21 07:03 ET

Express News | Mira Pharmaceuticals Inc - Reports Ketamir-2 Outperforms Current FDA-Approved Neuropathic Pain Treatments in Preclinical Study

ReutersOct 21 07:02 ET

Mira Pharmaceuticals Analyst Ratings

BenzingaSep 30 12:51 ET · Ratings

Mira Pharmaceuticals Initiated With a Buy at Rodman & Renshaw

TipRanksSep 30 09:40 ET · Ratings